SG
Shrikant Gopichand Patole
About Shrikant Gopichand Patole
Data last updated:
Shrikant Gopichand Patole is a Director at Mylab Discovery Solutions Private Limited (since 2020), Designated Partner at Dynergix Llp (since 2026) and Director at Autophoresis Technologies Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Life Sciences, Information Technology and Healthcare. The largest current company by reported revenue is Mylab Discovery Solutions Private Limited at ₹153 Cr (FY 2024). Earlier, Shrikant Gopichand Patole was an Additional Director at Alliance Transfusion Private Limited (2012–2014) and Designated Partner at Elderberry Diagnostics Llp (2019–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2020 | 2016 | ₹153 Cr (FY 2024) | Active | |
| Designated Partner | 23 Jul 2026 | 2026 | Active | ||
| Director | 01 Sep 2025 | 2025 | Active | ||
| Partner | 17 Feb 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 14 Aug 2012 | 2010 | ₹2.77 Cr (FY 2025) | Active | |
| Designated Partner | 21 Aug 2019 | 2016 | Active | ||
| Designated Partner | 10 Mar 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shrikant Gopichand Patole
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gautam Ravishekhar Wankhede | 03286480 | Mylab Discovery Solutions Private Limited , Eternal Softech Opportunities Llp | Director |
| Gunvant Vilas Gaikwad | Mylab Discovery Solutions Private Limited | Company Secretary | |
| Hasmukh Sohanraj Rawal | 03566044 | Mylab Discovery Solutions Private Limited | Managing Director |
| Rahul Subhash Patil | 07424402 | Mylab Discovery Solutions Private Limited | Director |
| Shailendra Balasaheb Kawade | 07527160 | Mylab Discovery Solutions Private Limited , Eternal Softech Opportunities Llp | Director |
| Sujit Sohanlal Jain | 01463586 | Mylab Discovery Solutions Private Limited | Director |
| Debarshi Bimal Dey | 06489574 | Dynergix Llp | Designated Partner |
| Sagar Nagorao Kumbhare | 08538115 | Autophoresis Technologies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shrikant Gopichand Patole
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shrikant Gopichand Patole
Shrikant Gopichand Patole currently holds 4 directorships: Mylab Discovery Solutions Private Limited (Director, since 01 Apr 2020, revenue ₹153 Cr (FY 2024)); Dynergix Llp (Designated Partner, since 23 Jul 2026); Autophoresis Technologies Private Limited (Director, since 01 Sep 2025); Eternal Softech Opportunities Llp (Partner, since 17 Feb 2022).
Shrikant Gopichand Patole was first appointed on 14 Aug 2012 as Additional Director at Alliance Transfusion Private Limited. The most recent appointment on record is 23 Jul 2026 at Dynergix Llp.
Shrikant Gopichand Patole held 3 earlier board appointments: Alliance Transfusion Private Limited (Additional Director, 14 Aug 2012 to 29 Jul 2014); Elderberry Diagnostics Llp (Designated Partner, 21 Aug 2019 to 21 Feb 2020); Kaizen Scientific Medicare Llp (Designated Partner, from 10 Mar 2015).
The current boards of Shrikant Gopichand Patole's companies include Gautam Ravishekhar Wankhede (Mylab Discovery Solutions Private Limited), Gunvant Vilas Gaikwad (Mylab Discovery Solutions Private Limited), Hasmukh Sohanraj Rawal (Mylab Discovery Solutions Private Limited), Rahul Subhash Patil (Mylab Discovery Solutions Private Limited), Shailendra Balasaheb Kawade (Mylab Discovery Solutions Private Limited), Sujit Sohanlal Jain (Mylab Discovery Solutions Private Limited), among others.